More clues revealed about the causes of an allergic inflammation of the esophagus

The condition is often misdiagnosed as GERD

10:49 AM

Author | Kelly Malcom

microscope
Jacob Dwyer, Justine Ross, Michigan Medicine

Food allergies most often bring to mind reactions like hives or an upset stomach. But a relatively recently recognized condition, known as eosinophilic esophagus or EOE, links allergic reactions to a distressing and sometimes dangerous inflammation of the tube connecting the mouth to the stomach. 

A recent study from U-M offers more insight into the underlying causes of EOE.

EOE was discovered in the 90s and is often confused for a more familiar condition known as GERD, which can cause stomach acid to flow backwards into the esophagus. EOE and GERD share similar symptoms, but EOE is characterized by a thickening of the walls of the esophagus, which can cause food to get stuck when swallowing.

Sahiti Marella, Ph.D., working in the lab of Simon Hogan, Ph.D., the Askwith Research Professor of Food Allergy at the Mary H. Weiser Food Allergy Center and Professor of Pathology at U-M Medical School, was interested in the drivers behind the proliferation of cells of the esophageal lining. 

Previous work in the field pointed to an immune protein, or cytokine, called IL-13 as the culprit behind inflammation and the remodeling of the lining of the esophagus leading to EOE. 

But Marella wondered what exactly IL-13 was doing to lead to disease. 

Using a publicly available database of biopsies from patients with EOE, the team generated RNA sequencing data of cells cultured from people with and without the condition to look for genetic differences that may underlie IL-13’s inflammatory effects. 

They found 82 common differentially expressed genes that were enriched for STAT3 target genes. 

STAT3 is a transcription factor responsible for the regulation of many cellular functions throughout the body. 

Furthermore, 32 of the 82 genes were targets of STAT3, which has been implicated in cell proliferation with cancer. 

Looking at the 32 STAT3 target genes, they identified one that was also associated with cell proliferation called SFRP1.

In cancer, SFRP1 protein is lost, leading to the out-of-control proliferation of cells. 

However, the U-M team found that SFRP1 mRNA is increased in esophageal biopsies from patients with active EOE compared with healthy controls or patients in remission. 

This fact, Marella explains, could be the reason that EOE, unlike GERD, does not progress to cancer. 

Building on this work, Marella plans to further study SFRP1’s role in the proinflammatory and thickening of the esophageal lining.

This work was supported in part by the University of Michigan Orthopaedic Research Laboratories Histology Core and the University of Michigan Medical School Microscopy Core.

Paper cited: “IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis," Journal of Allergy and Clinical Immunology. DOI: 10.1016/j.jaci.2023.07.021

 


More Articles About: Reflux or GERD Gastroenterology Swallowing problems or Dysphagia Voice & Swallowing
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories cutting board close up person cutting food with olive oil on side
Health Lab
Mediterranean diet provides symptom relief for patients with IBS in pilot study
A pilot study found that the Mediterranean diet may provide symptom relief for people with irritable bowel syndrome commonly referred to as IBS.
red cancer cell on red background
Health Lab
Researchers identify roles of key genes in colon cancer development
Researchers used mouse models and studies of colorectal cancer tissues to show that loss of SOX9 gene promotes tumor progression and the pathway it regulates can be a potential target for future treatments.
bent over holding stomach pink shirt sitting
Health Lab
FDA approves gastrointestinal device
The FDA approved a device developed at the University of Michigan that allows doctors to diagnose and predict treatment outcomes for individuals with chronic constipation far earlier than other methods.
drawing of scientists and doctors up close to insides of stomach
Health Lab
How a phone call led Michigan Medicine to become a leader in treating severe ulcerative colitis
Michigan Medicine becomes leader in treating severe ulcerative colitis with JAK inhibitors.
shot in arm patient rolled up sleeve
Health Lab
Why anti-TNF drugs don’t work for some kids with Crohn's disease
Research from Michigan Medicine investigated possible genetic factors for drug efficacy for children with Crohn’s disease. 
syringes three in a row with one with a shot going into it on a light teal background
Health Lab
TNF inhibitors prevent complications in kids with Crohn’s disease, recommended as first-line therapies
Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas in Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data.